The Effect of Low-dose Interleukin-2 on the Immune Landscape of Human Atherosclerotic Plaques at Single Cell Resolution.

Conditions:   TIA;   Carotid Artery Plaque;   Carotid Atherosclerosis Interventions:   Drug: Interleukin-2 [IL-2];   Procedure: Standard care - Carotid Endarterectomy Sponsor:   Cambridge University Hospitals NHS Foundation Trust Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials